Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Semih U Tareen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Virology|November 2, 2010
Human Trim5α has additional activities that are uncoupled from retroviral capsid recognitionSemih U Tareen, Michael Emerman
Cell Host & Microbe|May 18, 2011
Trim5 TAKes on pattern recognitionSemih U Tareen, Michael Emerman
Virology|January 17, 2009
An expanded clade of rodent Trim5 genesSemih U Tareen, Sara L Sawyer, Harmit S Malik, et al.
The Journal of Biological Chemistry|July 26, 2002
The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formationSeng-Lai Tan, Semih U Tareen, Mark W Melville, et al.
AIDS Research and Human Retroviruses|September 29, 2020
Real-Time Killing Assays to Assess the Potency of a New Anti-Simian Immunodeficiency Virus Chimeric Antigen Receptor T CellFrançoise Haeseleer, Karsten Eichholz, Semih U Tareen, et al.
Bioresearch Open Access|January 1, 2014
A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral VectorsSemih U Tareen, Christopher J Nicolai, David J Campbell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2015
Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapyJared M Odegard, Brenna Kelley-Clarke, Semih U Tareen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2014
Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cellsSemih U Tareen, Brenna Kelley-Clarke, Christopher J Nicolai, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectorsDaniel C Farley, Laura McCloskey, Barbara A Thorne, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Virology|November 2, 2010
Human Trim5α has additional activities that are uncoupled from retroviral capsid recognitionSemih U Tareen, Michael Emerman
Cell Host & Microbe|May 18, 2011
Trim5 TAKes on pattern recognitionSemih U Tareen, Michael Emerman
Virology|January 17, 2009
An expanded clade of rodent Trim5 genesSemih U Tareen, Sara L Sawyer, Harmit S Malik, et al.
The Journal of Biological Chemistry|July 26, 2002
The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formationSeng-Lai Tan, Semih U Tareen, Mark W Melville, et al.
AIDS Research and Human Retroviruses|September 29, 2020
Real-Time Killing Assays to Assess the Potency of a New Anti-Simian Immunodeficiency Virus Chimeric Antigen Receptor T CellFrançoise Haeseleer, Karsten Eichholz, Semih U Tareen, et al.
Bioresearch Open Access|January 1, 2014
A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral VectorsSemih U Tareen, Christopher J Nicolai, David J Campbell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2015
Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapyJared M Odegard, Brenna Kelley-Clarke, Semih U Tareen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2014
Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cellsSemih U Tareen, Brenna Kelley-Clarke, Christopher J Nicolai, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectorsDaniel C Farley, Laura McCloskey, Barbara A Thorne, et al.
Pageof 1